Skip to content
healthcare.dev

Oxybutynin Chloride Extended Release

NDC 42291-635, Oxybutynin Chloride, tablet, extended release, from AvKARE.

Product NDC
42291-635
Status
Listed
Labeler
AvKARE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078503
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42291-635 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE15 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
42291-635-0142291063501100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-635-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/94471401-a516-0fe7-ec9c-447dd2bee972

Use it

Look up 42291-635 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42291-635 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42291-635. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.